• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用铜-64对与TETA和CB-TE2A偶联的肽进行放射性标记。

Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.

作者信息

Wadas Thaddeus J, Anderson Carolyn J

机构信息

Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, Campus Box 8225, St. Louis, Missouri 63110, USA.

出版信息

Nat Protoc. 2006;1(6):3062-8. doi: 10.1038/nprot.2006.431.

DOI:10.1038/nprot.2006.431
PMID:17406569
Abstract

The number of radiopharmaceuticals containing copper radionuclides for diagnostic imaging and targeted radiotherapy has grown considerably over the past few decades. This expansion has created the need for protocols allowing for the efficient chelation of 64Cu to peptide-chelator conjugates. Step 1A of this protocol describes a (64)Cu-radiolabeling procedure for 1,4,8,11-tetraazacyclododecane-1,4,8,11-tetraacetic acid (TETA)-conjugated peptides. This reaction is facile and requires the incubation of 64CuCl2 in 0.1 M ammonium acetate buffer with the TETA-peptide for 30 min at room temperature (20-23 degrees C). Step 1B of this protocol describes the radiolabeling procedure for 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane (CB-TE2A)-conjugated peptides. The CB-TE2A-peptide can be labeled with 64Cu in 0.1 M ammonium acetate buffer in 2 h at 95 degrees C. In both cases, the conjugates can be radiolabeled with 64Cu at greater than 95% purity and with specific activities of 37-111 MBq microg(-1) (1-3 mCi microg(-1)). Both protocols are straightforward and can be completed within 3 h.

摘要

在过去几十年中,用于诊断成像和靶向放疗的含铜放射性药物的数量大幅增长。这种增长使得需要有相应方案来实现64Cu与肽 - 螯合剂共轭物的高效螯合。本方案的步骤1A描述了一种用于1,4,8,11 - 四氮杂环十二烷 - 1,4,8,11 - 四乙酸(TETA)共轭肽的(64)Cu放射性标记程序。该反应简便,需要在室温(20 - 23摄氏度)下,将64CuCl2在0.1 M醋酸铵缓冲液中与TETA - 肽孵育30分钟。本方案的步骤1B描述了4,11 - 双(羧甲基)-1,4,8,11 - 四氮杂双环[6.6.2]十六烷(CB - TE2A)共轭肽的放射性标记程序。CB - TE2A - 肽可以在95摄氏度下于0.1 M醋酸铵缓冲液中用64Cu标记2小时。在这两种情况下,共轭物都可以用64Cu进行放射性标记,纯度大于95%,比活度为37 - 111 MBq μg(-1)(1 - 3 mCi μg(-1))。这两个方案都很简单,并且可以在3小时内完成。

相似文献

1
Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.用铜-64对与TETA和CB-TE2A偶联的肽进行放射性标记。
Nat Protoc. 2006;1(6):3062-8. doi: 10.1038/nprot.2006.431.
2
Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.铜-64标记的交联和传统四氮杂大环配合物的体内稳定性比较
J Med Chem. 2004 Mar 11;47(6):1465-74. doi: 10.1021/jm030383m.
3
Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.使用交联大环螯合剂制备铜-64标记的酪胺酸3-奥曲肽及其生物学评价
Clin Cancer Res. 2004 Dec 15;10(24):8674-82. doi: 10.1158/1078-0432.CCR-04-1084.
4
An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.一种新型笼状双功能螯合剂 4-((8-氨基-3,6,10,13,16,19-六氮杂双环[6.6.6]icosane-1-基氨基)甲基)苯甲酸的改进合成及生物评价及其用于 64Cu 放射性药物。
Nucl Med Biol. 2010 Jan;37(1):57-65. doi: 10.1016/j.nucmedbio.2009.09.001. Epub 2009 Oct 12.
5
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.铜-64标记的交联环胺配体的放射性标记及体内行为
J Med Chem. 2002 Jan 17;45(2):469-77. doi: 10.1021/jm0103817.
6
In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.使用64Cu蛙皮素类似物对前列腺癌小鼠模型进行体内评估及小动物PET/CT成像:CB-TE2A与DOTA螯合系统的并列比较
J Nucl Med. 2007 Aug;48(8):1327-37. doi: 10.2967/jnumed.107.039487. Epub 2007 Jul 13.
7
Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.(64)Cu 标记的 Tyr(3)-奥曲肽的膦酸基交联大环螯合剂的制备及生物学评价。
Bioconjug Chem. 2012 Jul 18;23(7):1470-7. doi: 10.1021/bc300092n. Epub 2012 Jun 18.
8
Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line.64Cu标记的螯合生长抑素缀合物在转染了SSTr2的人肿瘤细胞系中的核摄取及剂量测定
J Nucl Med. 2007 Aug;48(8):1390-6. doi: 10.2967/jnumed.107.039990. Epub 2007 Jul 13.
9
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.使用64Cu标记的RGD肽对甲状旁腺激素诱导的骨溶解中的破骨细胞进行无创成像。
J Nucl Med. 2007 Feb;48(2):311-8.
10
Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice.HTE1PA的放射性标记:一种用于铜-64表型成像的新型单吡啶甲酸环胺衍生物。小鼠体内外稳定性研究。
Nucl Med Biol. 2014 May;41 Suppl:e49-57. doi: 10.1016/j.nucmedbio.2013.12.009. Epub 2013 Dec 18.

引用本文的文献

1
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands.螯合剂影响:研究铜-64标记的PD-L1放射性配体的药代动力学行为。
EJNMMI Radiopharm Chem. 2024 Feb 19;9(1):14. doi: 10.1186/s41181-024-00243-5.
2
Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of Ga Labeling and Complex Stability Characteristics with Established Chelators.双官能交联螯合剂的合成、肽键连接,以及与已建立的螯合剂比较 Ga 标记和络合物稳定性特征。
ChemMedChem. 2023 Jan 3;18(1):e202200495. doi: 10.1002/cmdc.202200495. Epub 2022 Nov 7.
3
Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.
放射性核素治疗药物铜螯合物与富 S 大环的配合:从放射性核素标记 64Cu 到体内研究。
Molecules. 2022 Jun 28;27(13):4158. doi: 10.3390/molecules27134158.
4
Synthesis of DOTA-pyridine chelates for Cu coordination and radiolabeling of αMSH peptide.用于铜配位及α-MSH肽放射性标记的DOTA-吡啶螯合物的合成。
EJNMMI Radiopharm Chem. 2021 Jan 13;6(1):3. doi: 10.1186/s41181-020-00119-4.
5
ImmunoPET: Concept, Design, and Applications.免疫正电子发射断层扫描:概念、设计与应用。
Chem Rev. 2020 Apr 22;120(8):3787-3851. doi: 10.1021/acs.chemrev.9b00738. Epub 2020 Mar 23.
6
Copper-Bispidine Complexes: Synthesis and Complex Stability Study.铜-联吡啶配合物:合成与配合物稳定性研究
ACS Omega. 2016 Nov 8;1(5):854-867. doi: 10.1021/acsomega.6b00237. eCollection 2016 Nov 30.
7
Synthesis and evaluation of Cu-radiolabeled NOTA-cetuximab (Cu-NOTA-C225) for immuno-PET imaging of EGFR expression.用于表皮生长因子受体(EGFR)表达免疫正电子发射断层显像(immuno-PET)成像的铜标记的N-羟基琥珀酰亚胺(NOTA)-西妥昔单抗(Cu-NOTA-C225)的合成与评估
Chin J Cancer Res. 2019 Apr;31(2):400-409. doi: 10.21147/j.issn.1000-9604.2019.02.14.
8
Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu Using NOTA and NODAGA.采用 NOTA 和 NODAGA 标记的抗 HER2 亲和体分子的比较评估。
Contrast Media Mol Imaging. 2017 Feb 28;2017:8565802. doi: 10.1155/2017/8565802. eCollection 2017.
9
Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker.基于肽的肿瘤限制性白细胞介素13受体A2生物标志物的正电子发射断层显像
Oncotarget. 2017 Mar 24;8(31):50997-51007. doi: 10.18632/oncotarget.16549. eCollection 2017 Aug 1.
10
New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging.用于铜-64的新型双功能螯合剂对-硫氰基苯丙基-NE3TA:合成、拟肽缀合、放射性标记及正电子发射断层显像评估
Inorg Chem. 2016 Jul 18;55(14):6892-901. doi: 10.1021/acs.inorgchem.6b00395. Epub 2016 Jun 27.